Aequus Pharmaceuticals Inc Capital Reinvestment Ratio

Latest as of June 2020: 1.32x

Aequus Pharmaceuticals Inc capital reinvestment ratio. Aequus Pharmaceuticals Inc (AQS) has a Capital Reinvestment Ratio of 1.32x as of June 2020, meaning it reinvests 1% of its operating cash flow (CA$9.36K) in capital expenditures (CA$12.32K). Check AQS capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.32x

Capex / Operating Cash Flow

Operating Cash Flow

CA$9.36K

CAD

Capital Expenditures

CA$12.32K

CAD

Data as of

Jun 2020

Most recent filing

Aequus Pharmaceuticals Inc Capital Reinvestment Ratio by Year (None–None)

Aequus Pharmaceuticals Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash efficiency ratio of Aequus Pharmaceuticals Inc.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow